Related references
Note: Only part of the references are listed.Overview of MicroRNA Biology
Ashley M. Mohr et al.
SEMINARS IN LIVER DISEASE (2015)
Genetic Mutation of p53 and Suppression of the miR-17∼92 Cluster Are Synthetic Lethal in Non-Small Cell Lung Cancer due to Upregulation of Vitamin D Signaling
Robert Borkowski et al.
CANCER RESEARCH (2015)
GPER mediated estradiol reduces miR-148a to promote HLA-G expression in breast cancer
Sifeng Tao et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)
microRNA-141 inhibits cell proliferation and invasion and promotes apoptosis by targeting hepatocyte nuclear factor-3β in hepatocellular carcinoma cells
Li Lin et al.
BMC CANCER (2014)
TRPM3 and miR-204 Establish a Regulatory Circuit that Controls Oncogenic Autophagy in Clear Cell Renal Cell Carcinoma
Daniel P. Hall et al.
CANCER CELL (2014)
MicroRNA-148a is downregulated in gastric cancer, targets MMP7, and indicates tumor invasiveness and poor prognosis
Naoya Sakamoto et al.
CANCER SCIENCE (2014)
MiR-365 induces gemcitabine resistance in pancreatic cancer cells by targeting the adaptor protein SHC1 and pro-apoptotic regulator BAX
Shin Hamada et al.
CELLULAR SIGNALLING (2014)
The role of miR-148a in gastric cancer
Jiazeng Xia et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2014)
Tumor suppressor miR-24 restrains gastric cancer progression by downregulating RegIV
Yantao Duan et al.
MOLECULAR CANCER (2014)
MiR-148a regulates MEG3 in gastric cancer by targeting DNA methyltransferase 1
Jiang Yan et al.
MEDICAL ONCOLOGY (2014)
MicroRNA-148a suppresses the epithelial-mesenchymal transition and metastasis of hepatoma cells by targeting Met/Snail signaling
J-P Zhang et al.
ONCOGENE (2014)
The Repressive Effect of miR-148a on TGF beta-SMADs Signal Pathway Is Involved in the Glabridin-Induced Inhibition of the Cancer Stem Cells-Like Properties in Hepatocellular Carcinoma Cells
Fei Jiang et al.
PLOS ONE (2014)
Investigation of miR-21, miR-141, and miR-221 expression levels in prostate adenocarcinoma for associated risk of recurrence after radical prostatectomy
Qizhi Zheng et al.
PROSTATE (2014)
Decreased expression and clinical significance of miR-148a in hepatocellular carcinoma tissues
Linjiang Pan et al.
EUROPEAN JOURNAL OF MEDICAL RESEARCH (2014)
Deregulation of PI3K/Akt/mTOR Signaling Pathways by Isoflavones and its Implication in Cancer Treatment
Aamir Ahmad et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2013)
Gastrin acting on the cholecystokinin2 receptor induces cyclooxygenase-2 expression through JAK2/STAT3/PI3K/Akt pathway in human gastric cancer cells
Wei Xu et al.
CANCER LETTERS (2013)
Linking JNK-STAT3-Akt signaling axis to EZH2 phosphorylation: A novel pathway of carcinogenesis
Yon Rojanasakul
CELL CYCLE (2013)
JNK and STAT3 signaling pathways converge on Akt-mediated phosphorylation of EZH2 in bronchial epithelial cells induced by arsenic
Bailing Chen et al.
CELL CYCLE (2013)
Progastrin Stimulates Colonic Cell Proliferation via CCK2R-and β-Arrestin-Dependent Suppression of BMP2
Guangchun Jin et al.
GASTROENTEROLOGY (2013)
Proton pump inhibitor selectively suppresses proliferation and restores the chemosensitivity of gastric cancer cells by inhibiting STAT3 signaling pathway
Shuling Huang et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2013)
ADAMTS9 is a functional tumor suppressor through inhibiting AKT/mTOR pathway and associated with poor survival in gastric cancer
W. Du et al.
ONCOGENE (2013)
Mycophenolic Acid Inhibits Migration and Invasion of Gastric Cancer Cells via Multiple Molecular Pathways
Boying Dun et al.
PLOS ONE (2013)
microRNA-148a suppresses human gastric cancer cell metastasis by reversing epithelial-to-mesenchymal transition
Sui-Han Wang et al.
TUMOR BIOLOGY (2013)
A single nucleotide polymorphism of the cholecystokinin-B receptor predicts risk for pancreatic cancer
Jill P. Smith et al.
CANCER BIOLOGY & THERAPY (2012)
JNK-Induced Apoptosis, Compensatory Growth, and Cancer Stem Cells
Fei Chen
CANCER RESEARCH (2012)
Targeting STAT3 in gastric cancer
Andrew S. Giraud et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2012)
MicroRNA-148b suppresses cell growth by targeting cholecystokinin-2 receptor in colorectal cancer
Yongxi Song et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Comparisons of Gastric Cancer Treatments: East vs. West
Kai Bickenbach et al.
JOURNAL OF GASTRIC CANCER (2012)
STAT3 Plays a Critical Role in KRAS-Induced Pancreatic Tumorigenesis
Ryan B. Corcoran et al.
CANCER RESEARCH (2011)
MicroRNA-148a Suppresses Tumor Cell Invasion and Metastasis by Downregulating ROCK1 in Gastric Cancer
Biqiang Zheng et al.
CLINICAL CANCER RESEARCH (2011)
miR-126 functions as a tumour suppressor in human gastric cancer
Runhua Feng et al.
CANCER LETTERS (2010)
Novel STAT3 Phosphorylation Inhibitors Exhibit Potent Growth-Suppressive Activity in Pancreatic and Breast Cancer Cells
Li Lin et al.
CANCER RESEARCH (2010)
The Silencing of MicroRNA 148a Production by DNA Hypermethylation Is an Early Event in Pancreatic Carcinogenesis
Naima Hanoun et al.
CLINICAL CHEMISTRY (2010)
MicroRNA-21 and MicroRNA-148a Contribute to DNA Hypomethylation in Lupus CD4+ T Cells by Directly and Indirectly Targeting DNA Methyltransferase 1
Wen Pan et al.
JOURNAL OF IMMUNOLOGY (2010)
Blocking gastrin and CCK-B autocrine loop affects cell proliferation and apoptosis in vitro
Jian Jiang Zhou et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2010)
Karyotype-specific microRNA signature in chronic lymphocytic leukemia
Rosa Visone et al.
BLOOD (2009)
MicroRNAs: Target Recognition and Regulatory Functions
David P. Bartel
CELL (2009)
Share Paper
